Ligand validation:4TRO

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 4TRO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4TRO_NAD_A_301	98%	33%	0.064	0.986	1.16	1.48	4	9	2	0	100%	0.5
2X23_NAD_A_1270	100%	24%	0.045	0.992	1.42	1.68	5	9	0	0	100%	1
4TZK_NAD_A_500	99%	63%	0.058	0.988	0.64	0.79	-	1	0	0	100%	0.99
4D0S_NAD_C_1270	99%	62%	0.054	0.982	0.69	0.76	-	1	0	0	100%	1
5MTR_NAD_E_301	99%	37%	0.057	0.984	1.39	1.11	3	5	1	0	100%	1
5MTP_NAD_A_301	98%	47%	0.062	0.986	0.86	1.18	2	5	0	0	100%	1
3CMC_NAD_O_407	100%	18%	0.022	0.996	1.63	1.92	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.